Dermatology · New York, NY
NPI
1255757134
Since 2014
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
77 Park Ave
New York, NY, 10016
Phone (212) 826-6999
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,449
47 services
Medicare patients, 2024
20
Average age 69
Drug cost, 2024
$2.3M
5,627 prescriptions
Company payments, 2025
$1,285
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lyudmila Magakyan-Martinez was code 99213 (office e&m - established), 21 times for 17 patients. In total Lyudmila Magakyan-Martinez billed 47 services in 6 codes, and Medicare paid $3,449.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 21 | 17 | $64.13 | $1,347 |
By year: 2022 $36K for 652 services; 2023 $6,688 for 104 services; 2024 $3,449 for 47 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lyudmila Magakyan-Martinez prescribed most often to Medicare patients was Metronidazole, with 591 prescriptions and refills. In total Lyudmila Magakyan-Martinez wrote 5,627 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metronidazole Generic | 591 | 594 | 165 | $42K |
| Ketoconazole Generic | 538 | 548 | 221 | $12K |
| Fluocinonide Generic | 354 | 354 | 73 | $30K |
| Fluocinolone Acetonide Generic | 276 | 276 | 131 | $11K |
| Triamcinolone Acetonide Generic | 275 | 356 | 172 | $18K |
| Mometasone Furoate Generic | 251 | 260 | 120 | $5,003 |
| Tacrolimus Generic | 242 | 243 | 99 | $40K |
| Pimecrolimus Generic | 239 | 250 | 127 | $66K |
| Fluticasone Propionate Generic | 190 | 190 | 95 | $6,262 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 164 | 173 | 79 | $9,757 |
| Clobetasol Propionate Generic | 159 | 159 | 73 | $17K |
| Ciclopirox Generic | 155 | 158 | 67 | $4,151 |
| Methotrexate Methotrexate Sodium | 130 | 133 | 55 | $950 |
| Halobetasol Propionate Generic | 112 | 114 | 54 | $10K |
| Betamethasone Dipropionate Generic | 103 | 103 | 54 | $2,828 |
Brand drugs: - claims; generic drugs: 5,097 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lyudmila Magakyan-Martinez $1,285 ($1,285 in general payments such as food, travel and fees) from 17 companies. The largest payer was Pfizer Inc. with $309.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 29 | $309 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 15 | $236 |
| LEO Pharma Inc. | 15 | $179 |
| Abbvie Inc. ABBV | 17 | $176 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $99 |
| Genzyme Corporation SNY | 4 | $70.93 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $47.12 |
| Janssen Biotech, Inc. JNJ | 1 | $21.49 |
| Incyte Corporation INCY | 1 | $18.81 |
| Botanix SB Inc | 1 | $18.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.